Transitions from peritoneal dialysis to hemodialysis are common during kidney replacement therapy and may be associated with adverse outcomes. However, the incidence, predictors, and outcomes of PD-to-HD transitions at a national level remain incompletely characterized.
This study will use Canadian dialysis and hospitalization databases to examine the epidemiology and outcomes of PD-to-HD transitions among adults initiating dialysis in Canada. The study will evaluate transition incidence, predictors, and post-transition outcomes including mortality, transplantation, modality changes, and hospitalizations.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Adults (≥18 years)
* Dialysis initiation in Canada between January 1, 2005 and December 31, 2018
* Peritoneal dialysis duration \>30 consecutive days
Exclusion Criteria:
* Dialysis initiation in Quebec or Manitoba during the study period
* Dialysis initiation in a foreign country
* Missing data on initial dialysis modality
* Pre-emptive kidney transplantation
Primary outcome measure(s)
Incidence of transfer from peritoneal dialysis to hemodialysis — From PD initiation until 1-year after PD start Also assessed at from PD initation until 2- and 5-year after PD start. Measured as cumulative incidence and incidence rate of transitions following initiation of PD and censored at time of death, kidney transplantation, transfer home hemodialysis, or administrative end of follow-up.
Trial sites (1)
Facility
City
Region
Status
CIUSSS de l'Est-de-l'ile de Montréal
Montreal
Quebec
More Ciusss de L'Est de l'Île de Montréal trials in Canada
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.